Retatrutide | 10mg
- Batch and lot coded with publicly visible lab reports to ensure quality and transparency.
- Free of adulterants, excipients, and flow agents to ensure purity.
- Tamper-proof seal to ensure safety in transit.
- RTF vials are Washed, Depyrogented, and ETO Sterilized.
- Aliquot injectable vials are fully sterilized and filtered.
$129.99 – $1,100.00Price range: $129.99 through $1,100.00
| Title | Range | Discount |
|---|---|---|
| Bulk/tiered discount | 1 - 3 | 0% $129.99 |
| Bulk/tiered discount | 4 - 6 | 10% $116.99 |
| Bulk/tiered discount | 7 - 10 | 15% $110.49 |
| Bulk/tiered discount | 11 - 15 | 20% $103.99 |
| Bulk/tiered discount | 16 - 25 | 22% $101.39 |
| Bulk/tiered discount | 26 - 30 | 25% $97.49 |
| Bulk/tiered discount | 31 + | 30% $90.99 |
5
People watching this product now!
Payment Methods:
Chemical Storage

Lab Results
Â
Dates
Date Added:
06/28/2025
Janoshik Lab Results

Chemical Information
Cas Number
2259884-03-0
PubChem CID
171378578
Molecular Weight
4860 g/mol
Molecular Formula
C227H354N48O69
Synonyms
GLXC-27530
Storage (Lyophilized)
Cool, Dry, and dark place. Refrigerated after reconstituted.
Description
Retatrutide – 10mg | Buy Retatrutide USA & Canada
Retatrutide is a next-generation multi-receptor peptide currently being studied for its role in metabolic regulation, weight management, and energy balance. It is known for its activity on GLP-1, GIP, and glucagon receptors, making it one of the most advanced compounds in metabolic research.
At StrateLabs, Retatrutide 10mg is supplied as a high-purity research peptide, handled under strict quality standards to ensure consistency and reliability. Customers looking to buy Retatrutide online in the USA or Canada can expect fast shipping, secure packaging, and a seamless ordering experience.
 Key Features & Highlights
- Triple receptor activity (GLP-1, GIP, glucagon)
- Widely studied for metabolic and weight regulation research
- High-purity peptide for research applications
- Long-acting profile in experimental studies
- Increasing interest in advanced peptide research









